2Sen R , Baltimore D. Multiple nuclear factors interact with immunoglobulin enhancer sequences[J]. Cell , 1986 , 46 (5) :705-716.
3Lawson IJ . Leukocyte mrgration into the certral nervows system. In : Rothwell NJ ed. Immune responses in the nervous system[ M ]. Bro Sctentrfic Rubrishers, 1995,11 (3) :27-36.
4Lee JK, Burckart GJ. Nuclear factor kappa B : important transcription factor and therapeutic target [ J ]. J Clin Pharmacol, 1998, 38 ( 11 ) : 981-993.
5Karin M , Yamamoto Y,Wang QM. The IKK NF 2 kappa B system: a treasure trove for drug development [ J ]. Nat Rev Drug Dis Cov, 2004, 3 (1) : 17-26.
6Wai K, Lee BR , Hashiguchi M ,et al. IkB 2 alpha 2 specific transcript regulation by the C 2 terminal end of c 2 Rel[J]. FEBS Lett, 2005 , 579 (1) :141-144.
7Rothwell N. Interleukinl and neuronal injury: Mechanisms, modification, and therapeutic potential [ J]. Brain Behav Immun, 2003,17 (3) :152-157.
8Patel HC, Boutin H, Allan SM. Interleukin 1 in the brain: Mechanisms of action in acute urodegeneration [ J ]. Ann N Y Acad Sci, 2003,99(2 ) :3947.
9Yang K, Mu XS, Hayes RL. Increased cortical nuclear factor-kappa B (NF-kappaB) DNA binding activity after traumatic brain injury in rats[J]. Neurosci Lett, 1995, 197(2) :101-104.
10Nonaka M, Chen XH, Pierce JE, et al. Prolonged activation of NF- kappa B following traumatic brain injury in rats [ J]. J Neurotrauma, 1999,16( 11 ) :1023-1034.
